Agios Pharmaceuticals, Inc. (AGIO)

Accolade Revenue

Agios Pharmaceuticals had revenue of $12.46M in the quarter ending June 30, 2025, with 44.57% growth. This brings the company's revenue in the last twelve months to $40.88M, up 30.57% year-over-year. In the year 2024, Agios Pharmaceuticals had annual revenue of $36.50M with 36.07% growth.

• Revenue (ttm): $40.88M
• Revenue Growth: +30.57%
• P/S Ratio: 52.93
• Revenue / Employee: $83,760
• Employees: 488
• Market Cap: 2.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.50M	9.68M	36.07%
Dec 31, 2023	26.82M	12.58M	88.36%
Dec 31, 2022	14.24M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.